Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection

NCT04636086 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-05-19

No results posted yet for this study

Summary

The objective of the study is to evaluate the clinical efficacy and safety of vitamin D supplementation in hospitalized patients with COVID-19.

Conditions

  • Covid19

Interventions

DRUG

Cholecalciferol

Vitamin D supplementation

OTHER

Placebo

Placebo comparator

Sponsors & Collaborators

  • Laboratoires SMB S.A.

    collaborator INDUSTRY
  • University of Liege

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-12
Primary Completion
2022-04-10
Completion
2022-05-15

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04636086 on ClinicalTrials.gov